In the current study we establish that LDLr-/- mice lacking CD1d-dependent NKT cells demonstrate reduced AAA severity in the most commonly used model to study the development and pathogenesis of AAA, the angiotensin II (Ang II) infusion model. The gene discussed is CD1D; the disease is triple-A syndrome.